Does GLP-1 Lower Estrogen? (October 2026)

01 · The core answer

Does GLP-1 lower estrogen? The honest short answer

The licensed description of how Mounjaro works does not describe any action on estrogen.

If you are on treatment and your symptoms have changed, the right route is a conversation with your prescriber or GP, not a guess from an article. If you want to read more on this topic, our guides on GLP-1 and estrogen explained and estrogen and Mounjaro cover related questions.

02 · Your decision

The decisions you are actually facing

Most readers are weighing one of three situations. You may be considering treatment and worry about hormones. You may already be taking it and have noticed new symptoms. Or you may be wondering whether hormone therapy and a weight-loss injection can sit side by side.

If you are considering treatment, the licensed criteria and your medical history matter most. Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber, and used alongside a reduced-calorie diet and increased physical activity.¹ Tell the prescriber about any hormone treatment you use, any contraception, and any menopause symptoms. That is the information that lets them judge suitability.

If you are already taking it and have new symptoms, do not stop or change doses on your own. Speak to the prescribing team or your GP, and consider reporting the symptom through the Yellow Card scheme.¹⁹

03 · What the label says

What the product information says about how Mounjaro works

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.

It names gut hormones, appetite, stomach emptying and insulin response. It does not mention estrogen, progesterone, testosterone or the ovaries. If you wonder whether a GLP-1 medicine lowers estrogen, estrogen is not part of the licensed mechanism as described.

That is different from proving there is never any knock-on effect in a given person. Bodies are interconnected, and appetite, weight and hormones influence one another.

The same caution applies to the direct comparison people often want with other GLP-1 medicines. Tirzepatide acts on two receptors, whereas semaglutide, the active ingredient in Wegovy and Ozempic, is a single-action GLP-1 medicine. Neither description includes an effect on estrogen. The Wegovy pen page sets out the licensed details of semaglutide.

For your own situation, the patient information leaflet in every pack is the document to read alongside your prescriber's advice.¹³ The prescribing reference for clinicians is the BNF entry for tirzepatide.¹¹

04 · Life-stage overlap

Why timing makes this question so confusing

Many adults start weight-loss treatment during the same years in which hormone changes are also under way. That overlap is the most common reason people connect the two. When symptoms appear soon after starting an injection, it is natural to assume the injection caused them. It may have, it may not have, and timing alone cannot tell you which.

Several things can change at once. Eating patterns shift because appetite is reduced. Body weight changes. Sleep, exercise and stress levels may also change as people take their health more seriously. Any of these can alter how you feel from week to week. Separating them out is a job for a clinician who knows your history, not for a general article.

A practical diary helps. Record when you took each dose, when the symptom appeared, how long it lasted and anything else that changed. The free GLPTrackr companion app and clinic support can help you keep that record together with your treatment journey. Bring it to your monthly review.

It also helps to say plainly if you are already being treated for a hormone-related condition. Your prescriber needs to know about hormone therapy, contraception and any recent changes to either. They can then judge whether a symptom is likely to relate to the injection, to something else, or to the timing of both.

The aim is not to dismiss your experience. It is to avoid blaming, or excusing, the medicine without evidence.

05 · Weight and hormones

Weight loss, body changes and hormones

Some websites explain hormone effects by pointing to body fat and weight loss.

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages, individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.

Those figures describe weight, not hormones. The trial results do not tell you what happened to estrogen in any participant. Large changes in body weight are a significant event for the body, and it is reasonable to expect that how you feel may change. How, and for whom, is a question for your prescriber.

It is also worth saying what we do not know about you. A trial average does not predict your own result, and it does not predict your own symptoms either. Someone with a long history of hormone-related health issues is in a different position from someone with none, and the right advice differs.

If you are curious whether estrogen itself influences weight, our page on estrogen and weight loss injections looks at that angle.

The practical message is steady. Weight management medicines work alongside diet and activity, results vary, and any new symptom during treatment deserves a conversation rather than speculation.

06 · HRT or GLP-1

Should you choose HRT or a GLP-1 medicine?

These two treatments do different jobs, so the question is rarely a straight either-or. Mounjaro is licensed for weight management in adults and for type 2 diabetes.¹ It is not licensed to treat menopause symptoms, and we do not offer it for that purpose. Hormone replacement is a separate prescribing decision, usually made with a GP or a menopause specialist.

Whether you can use both is something only a clinician with your full history can answer. What we ask is that you tell your prescriber about any hormone treatment during your consultation, so it is considered properly.

Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed.⁷ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ This applies to the pill only — implants, coils and injections are unaffected. If you rely on an oral contraceptive, discuss this with your prescriber before starting.

How should you decide what comes first? Start from your main problem. If your main concern is hormone-related symptoms, begin with your GP or a menopause service. If your main concern is weight and you meet the licensed criteria, a weight-management consultation is the right door. If it is both, say so at the start, and let the clinicians coordinate.

Avoid taking on treatments in a rush because an article suggested a combination. Adding or stopping a medicine without advice makes it harder to work out what is helping and what is causing trouble. You can read more about related questions in our guide on whether GLP-1 raises estrogen.

When you do speak to a clinician, a short list helps: your current medicines, any hormone products, contraception, the symptoms you want to address, and what you hope treatment will achieve.

07 · Symptoms to raise

What to do if you notice new symptoms on treatment

If you notice new or worrying symptoms during treatment, speak to your prescriber or GP and do not adjust your dose yourself. That applies whether the symptom seems hormonal, digestive or something you cannot name. Our prescribing team offers ongoing monthly reviews and side-effect support, so you do not have to work it out alone.

Many readers ask how a woman feels when her estrogen is low or high. Many different conditions share the same symptoms. A clinician can check what is going on, and testing or a conversation is better than self-diagnosis.

A symptom that is not on the UK patient leaflet's list is not a listed side effect.¹³ That does not mean your experience is unimportant. It means the right step is to report it so that it can be assessed.

The Yellow Card scheme, run by the MHRA, exists for exactly this purpose. You can report a suspected side effect yourself, and reports help regulators spot patterns.¹⁹ You do not need to be sure the medicine caused it.

Get medical help straight away for anything severe or sudden, such as severe or persistent stomach pain, swelling of the face, lips or throat, or difficulty breathing. For routine questions, our support team is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat, or by phone on 0333 207 0413.

When you contact us, tell us the dose you are on, when you last injected, and when the symptom began. That lets the prescribing team give a useful answer more quickly. Repeat orders re-check suitability, and nothing ships automatically, so your clinicians have regular chances to look at how you are doing.

08 · NHS and private

NHS access versus private treatment

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If hormone symptoms are your main concern, your GP is the route to NHS assessment, whatever you decide about weight treatment. The two conversations can happen in parallel, and it is worth mentioning both when you see your GP.

Private treatment is a personal choice, and the same safety expectations apply. A medicine of this kind should be supplied only after a consultation reviewed by a GPhC-registered prescriber. Be wary of any seller offering to supply without a consultation or prescription. Counterfeit and unregulated products are a recognised risk, and the MHRA publishes alerts and takes Yellow Card reports.⁷

You can check a pharmacy yourself on the public register. We are a GPhC-registered pharmacy, registration number 9012878, and you can verify us on the GPhC register.¹² Our Mounjaro comes from official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens.

Whichever route you take, keep your GP informed of what you are taking. That helps them look after your wider health, including any hormone-related care you are receiving.

09 · Ordering and aftercare

If you decide to start treatment: how it works

If you meet the licensed criteria and want to explore treatment, the process starts with a free online consultation. It is a short health questionnaire, with no charge and no obligation. This is the point to mention hormone treatment, contraception and any symptoms you are concerned about.

A GPhC-registered prescriber then reviews your answers. It is a clinical review, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Declined consultations are refunded in full.

Approved orders are dispensed by our registered pharmacy. We dispatch the same day when you order by 3pm, and delivery is free, next-day, tracked and sent in temperature-controlled, discreet packaging by DPD. Saturday delivery costs £14.99. Needles, a sharps bin and injection guidance come with every order.

Treatment starts at the lowest strength and steps up over time.

Ongoing monthly reviews, dose-titration and follow-up assessments are included, along with side-effect support. This is where you raise anything that has changed, including symptoms you wonder about. Repeat orders re-check suitability, and nothing is auto-shipped.

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹

Mounjaro (tirzepatide) is a prescription-only medicine, used alongside a reduced-calorie diet and increased physical activity. Individual results vary. This page is information, not a substitute for medical advice.

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹